{"id":"https://openalex.org/W2307280541","doi":"https://doi.org/10.1517/17425255.2016.1166204","title":"Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones","display_name":"Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones","publication_year":2016,"publication_date":"2016-03-16","ids":{"openalex":"https://openalex.org/W2307280541","doi":"https://doi.org/10.1517/17425255.2016.1166204","mag":"2307280541","pmid":"https://pubmed.ncbi.nlm.nih.gov/26982718"},"language":"en","primary_location":{"id":"doi:10.1517/17425255.2016.1166204","doi":"https://doi.org/10.1517/17425255.2016.1166204","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17425255.2016.1166204","pdf_url":null,"source":{"id":"https://openalex.org/S102336391","display_name":"Expert Opinion on Drug Metabolism & Toxicology","issn_l":"1742-5255","issn":["1742-5255","1744-7607"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Metabolism & Toxicology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083798648","display_name":"Dario Cattaneo","orcid":"https://orcid.org/0000-0003-1512-6530","observed_orcids":["https://orcid.org/0000-0003-1512-6530"]},"institutions":[{"id":"https://openalex.org/I4210087773","display_name":"Luigi Sacco Hospital","ror":"https://ror.org/0025g8755","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087773","https://openalex.org/I4210156709"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Dario Cattaneo","raw_affiliation_strings":["Unit of Clinical Pharmacology, Department of Laboratory Medicine, Luigi Sacco University Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Clinical Pharmacology, Department of Laboratory Medicine, Luigi Sacco University Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210087773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000820066","display_name":"Jan\u2010Willem C. Alffenaar","orcid":"https://orcid.org/0000-0001-6703-0288","observed_orcids":["https://orcid.org/0000-0001-6703-0288"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan-Willem Alffenaar","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026635936","display_name":"Michael Noel Neely","orcid":"https://orcid.org/0000-0002-1675-8276","observed_orcids":["https://orcid.org/0000-0002-1675-8276"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]},{"id":"https://openalex.org/I4405270452","display_name":"Saban Research Institute","ror":"https://ror.org/00qe7sv26","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405270452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Neely","raw_affiliation_strings":["Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angels, CA, USA","Laboratory of Applied Pharmacokinetics and Bioinformatics, The Saban Research Institute, Children\u2019s Hospital Los Angeles, Los Angels, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angels, CA, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Laboratory of Applied Pharmacokinetics and Bioinformatics, The Saban Research Institute, Children\u2019s Hospital Los Angeles, Los Angels, CA, USA","institution_ids":["https://openalex.org/I1336910626","https://openalex.org/I4405270452"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5083798648"],"corresponding_institution_ids":["https://openalex.org/I4210087773"],"apc_list":null,"apc_paid":null,"fwci":0.6463,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.53003003,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"12","issue":"5","first_page":"533","last_page":"544"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxazolidinones","display_name":"oxazolidinones","score":0.996999979019165},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tedizolid","display_name":"tedizolid","score":1.0},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9919999837875366},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.7699999809265137},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.968999981880188},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6880000233650208},{"id":"https://openalex.org/keywords/multidrug-resistant-tuberculosis","display_name":"multidrug-resistant tuberculosis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/extensively-drug-resistant-tuberculosis","display_name":"extensively drug-resistant tuberculosis","score":0.8019999861717224},{"id":"https://openalex.org/keywords/acute-bacterial-skin-and-skin-structure-infections","display_name":"acute bacterial skin and skin structure infections","score":0.8949999809265137},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8347386717796326},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.7606105804443359},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6726771593093872},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6630251407623291},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6585690975189209},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6066616177558899},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5768685936927795},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.5655609369277954},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5219918489456177},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4921233057975769},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.47466376423835754},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4645855724811554},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4286014437675476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20595905184745789},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.1515771746635437},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0691559910774231},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1517/17425255.2016.1166204","doi":"https://doi.org/10.1517/17425255.2016.1166204","is_oa":false,"landing_page_url":"https://doi.org/10.1517/17425255.2016.1166204","pdf_url":null,"source":{"id":"https://openalex.org/S102336391","display_name":"Expert Opinion on Drug Metabolism & Toxicology","issn_l":"1742-5255","issn":["1742-5255","1744-7607"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Metabolism & Toxicology","raw_type":"journal-article"},{"id":"pmid:26982718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26982718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug metabolism & toxicology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/fa6208e1-054a-4fd7-a9a3-b8e7542366e7","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/fa6208e1-054a-4fd7-a9a3-b8e7542366e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cattaneo, D, Alffenaar, J-W & Neely, M 2016, 'Drug monitoring and individual dose optimization of antimicrobial drugs : oxazolidinones', Expert Opinion on Drug Metabolism & Toxicology, vol. 12, no. 5, pp. 533-544. https://doi.org/10.1517/17425255.2016.1166204","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/fa6208e1-054a-4fd7-a9a3-b8e7542366e7","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/fa6208e1-054a-4fd7-a9a3-b8e7542366e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Drug Metabolism & Toxicology, 12(5), 533 - 544. TAYLOR & FRANCIS LTD","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":92,"referenced_works":["https://openalex.org/W173385639","https://openalex.org/W1529101966","https://openalex.org/W1964291085","https://openalex.org/W1968344443","https://openalex.org/W1970780793","https://openalex.org/W1971310740","https://openalex.org/W1972826015","https://openalex.org/W1973061988","https://openalex.org/W1977069647","https://openalex.org/W1981107394","https://openalex.org/W1982720496","https://openalex.org/W1985218263","https://openalex.org/W1987890120","https://openalex.org/W1992271563","https://openalex.org/W1993806447","https://openalex.org/W2002132121","https://openalex.org/W2003763065","https://openalex.org/W2010914626","https://openalex.org/W2014339040","https://openalex.org/W2017106430","https://openalex.org/W2017719546","https://openalex.org/W2021474252","https://openalex.org/W2025941714","https://openalex.org/W2026928559","https://openalex.org/W2027894704","https://openalex.org/W2029224554","https://openalex.org/W2038194207","https://openalex.org/W2042032983","https://openalex.org/W2048287611","https://openalex.org/W2052264066","https://openalex.org/W2060399504","https://openalex.org/W2060864608","https://openalex.org/W2061328414","https://openalex.org/W2069428985","https://openalex.org/W2072027560","https://openalex.org/W2077047735","https://openalex.org/W2080340920","https://openalex.org/W2080365958","https://openalex.org/W2080449868","https://openalex.org/W2082757002","https://openalex.org/W2087509275","https://openalex.org/W2092411341","https://openalex.org/W2095355032","https://openalex.org/W2095958193","https://openalex.org/W2097507993","https://openalex.org/W2099696892","https://openalex.org/W2105769537","https://openalex.org/W2109090890","https://openalex.org/W2109666263","https://openalex.org/W2113797892","https://openalex.org/W2114110528","https://openalex.org/W2120166315","https://openalex.org/W2120695593","https://openalex.org/W2121637951","https://openalex.org/W2122198633","https://openalex.org/W2122851467","https://openalex.org/W2127107038","https://openalex.org/W2128426670","https://openalex.org/W2129881065","https://openalex.org/W2132147287","https://openalex.org/W2132845302","https://openalex.org/W2133588004","https://openalex.org/W2134990478","https://openalex.org/W2135168021","https://openalex.org/W2136007937","https://openalex.org/W2144143337","https://openalex.org/W2144674162","https://openalex.org/W2145138274","https://openalex.org/W2146515240","https://openalex.org/W2147238867","https://openalex.org/W2148304777","https://openalex.org/W2150318743","https://openalex.org/W2151363711","https://openalex.org/W2151907467","https://openalex.org/W2153641174","https://openalex.org/W2153811332","https://openalex.org/W2160815516","https://openalex.org/W2161206754","https://openalex.org/W2162081207","https://openalex.org/W2164978693","https://openalex.org/W2167792428","https://openalex.org/W2202664828","https://openalex.org/W2253621615","https://openalex.org/W2278516944","https://openalex.org/W2312584567","https://openalex.org/W2313938220","https://openalex.org/W2328737381","https://openalex.org/W2334376858","https://openalex.org/W2464417828","https://openalex.org/W3141066191","https://openalex.org/W4211144518","https://openalex.org/W4232828423"],"related_works":["https://openalex.org/W2136007937","https://openalex.org/W4293152033","https://openalex.org/W2766105671","https://openalex.org/W2516905116","https://openalex.org/W4378194690","https://openalex.org/W136720919","https://openalex.org/W4211248818","https://openalex.org/W4322615462","https://openalex.org/W173385639","https://openalex.org/W7134033127"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Oxazolidinones":[1],"are":[2,54],"synthetic":[3],"antibiotics":[4],"with":[5,127],"bacteriostatic":[6],"activity":[7,19],"against":[8,20],"Gram-positive":[9],"pathogens.":[10],"Linezolid,":[11],"the":[12,41,64,79,86,95,121,142],"first":[13],"marketed":[14],"oxazolidinone,":[15],"has":[16,37],"shown":[17],"also":[18],"Mycobaterium":[21],"tuberculosis,":[22],"including":[23],"multidrug-resistant":[24],"and":[25,47,51,74,84,160,169,177],"extensively":[26],"drug-resistant":[27],"strains.":[28],"Recently,":[29],"a":[30],"second":[31],"agent":[32],"of":[33,43,81,88,98,145,165,184],"this":[34],"class":[35],"(tedizolid)":[36],"been":[38],"approved":[39],"for":[40,109,189],"treatment":[42],"acute":[44],"bacterial":[45],"skin":[46,48],"structure":[49],"infections,":[50],"other":[52,190],"oxazolidinones":[53,72,191],"under":[55],"active":[56],"investigation":[57],"in":[58,77,171],"clinical":[59,134,172],"trials.":[60,135],"AREAS":[61],"COVERED:":[62],"In":[63],"present":[65],"review,":[66],"we":[67,93],"consider":[68],"factors":[69],"that":[70,156],"affect":[71],"pharmacokinetics":[73],"their":[75],"role":[76,97,183],"reducing":[78],"effectiveness":[80],"these":[82],"drugs":[83],"increasing":[85],"risk":[87],"drug-related":[89],"adverse":[90],"events.":[91],"Furthermore,":[92],"review":[94],"potential":[96],"strategies":[99],"aimed":[100],"at":[101],"individualizing":[102],"drug":[103,130,158,186],"doses.":[104],"A":[105],"MEDLINE":[106],"PubMed":[107],"search":[108],"articles":[110],"published":[111],"from":[112,141],"January":[113],"1990":[114],"to":[115,174,180,193],"November":[116],"2015":[117],"was":[118],"completed":[119],"matching":[120],"terms":[122],"oxazolidinones,":[123],"linezolid,":[124],"or":[125,133],"tedizolid":[126],"pharmacokinetics,":[128],"therapeutic":[129,157],"monitoring,":[131],"pharmacology":[132],"Moreover,":[136],"additional":[137],"studies":[138],"were":[139],"identified":[140],"reference":[143],"list":[144],"retrieved":[146],"papers.":[147],"EXPERT":[148],"OPINION:":[149],"Consistent":[150],"evidence":[151],"is":[152,167],"now":[153],"available":[154],"showing":[155],"monitoring":[159],"guided":[161],"individual":[162],"dose":[163],"optimization":[164],"linezolid":[166],"justified":[168],"feasible":[170],"practice":[173],"improve":[175],"tolerability":[176],"possibly":[178],"response":[179],"therapy.":[181],"The":[182],"individualized":[185],"dosing":[187],"regimens":[188],"remains":[192],"be":[194],"proven.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}